Loading insider details...
Latest Form 4 (Nov 4, 2026): Other (see footnotes) of 4,603 SUPN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | Supernus, Inc. (SUPN) | Other (see footnotes) | 4,603 | n/a |
| Nov 4, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Other (see footnotes) | 24,153 | n/a |
| Jun 11, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Disposition to Issuer | 45,000 | n/a |
| Apr 17, 2026 | Alpha Cognition Inc. (ACOG) | Grant/Award | 5,489 | n/a |
| Feb 23, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 4,475 | n/a |
| Feb 20, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 2,989 | n/a |
| Oct 2, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/Award | 45,000 | n/a |
| Aug 18, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sale | 5,369 | $226.8K |
| Feb 24, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 5,369 | n/a |
| Feb 21, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 7,296 | n/a |